Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, Ottawa, Fairfax VA, Toronto, San Antonio TX,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06532565

Phase 1, Recruiting

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

for
Castration-Resistant Prostate Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04693377

Recruiting

Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06562777

Recruiting

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

for
Breast Carcinoma
Location: Chapel Hill NC, Jacksonville FL, Indianapolis IN,
Sponsor: Mayo Clinic

Sex: Female

Age: 18 - 45

Code: NCT05557877

Phase 2, Recruiting

Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors

for
Metastatic Solid Tumor, Locally Advanced Solid Tumor
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06358677

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

RAPA-201 Therapy of Solid Tumors

for
Solid Tumor, Small Cell and Non-small Cell Lung Cancer,
Location: Hackensack NJ
Sponsor: Rapa Therapeutics LLC

Sex: All

Age: 18+

Code: NCT05144698

Phase 1, Phase 2, Recruiting

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

for
Breast Cancer, Early Breast Cancer
Location: Winston-Salem NC, Irving TX, Aberdeen SD, Pierre SD
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05774951

Phase 3, Recruiting

Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06409065

Recruiting

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

for
Breast Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT06106477

Recruiting

Safety of PUR001 Monotherapy in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Houston TX
Sponsor: Purinomia Biotech, Inc.

Sex: All

Age: 18+

Code: NCT05234853

Phase 1, Recruiting

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, The Bronx NY, Baltimore MD, Miami FL,
Sponsor: DynamiCure Biotechnology

Sex: All

Age: 18+

Code: NCT05785754

Phase 1, Recruiting

XTX301 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, Hackensack NJ, Pittsburgh PA, Canton OH,
Sponsor: Xilio Development, Inc.

Sex: All

Age: 18+

Code: NCT05684965

Phase 1, Phase 2, Recruiting

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

for
Oncologic Surgery, Cancer, Cancer Surgery, Hepatic Cancer,
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: All

Age: 18 - 70+

Code: NCT06731998

Recruiting

Feasibility of Hyivy Device Post-Radiation for Pelvic Malignancies

for
Vaginal Stenosis, Radiation Therapy, Cancer, Pelvic Pain,
Location: Kitchener
Sponsor: Hyivy Health Inc

Sex: Female

Age: 18+

Code: NCT05648253

Recruiting

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

for
Breast Cancer, Lymphoma
Location: Tulsa OK, Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 70+

Code: NCT05921253

Early Phase 1, Recruiting

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

for
Advanced Malignant Solid Neoplasm,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT04511039

Phase 1, Recruiting

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Boston MA, Stony Brook NY, Mineola NY, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06380751

Phase 3, Recruiting

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors That Are MTAP Deficient
Location: Providence RI, New Haven CT, Baltimore MD, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06130553

Phase 1, Phase 2, Recruiting

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer,
Location: New York NY, Huntersville NC
Sponsor: GI Innovation, Inc.

Sex: All

Age: 18+

Code: NCT04977453

Phase 1, Phase 2, Recruiting

Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision

for
Cancer, Dementia
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 65+

Code: NCT06313853

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial